Skip to content

Public FDA record

Z-0110-2024: BD BACTEC Plus Aerobic/F Culture Vials, Catalog Number 442023

Recall record Z-0110-2024 for Becton Dickinson & Co.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0110-2024
Company in FDA record
Becton Dickinson & Co.
FDA classification date
Oct 12, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Certain vials of the BD BACTEC" Plus Aerobic/F Culture Vials have a labeling issue where duplicate barcode sequence numbers have been identified on more than one vial.

Source facts

Action
An URGENT: Medical Device Product Correction notification letter dated 9/12/23 was sent to customers. Please Take the Following Actions: 1. Immediately inspect your inventory for the specific catalog and lot numbers listed above to determine if the BD BACTEC" Plus Aerobic/F Culture Vials in your possession are impacted. 2. Ensure the contents of this Product Advisory are read and understood. 3. Share and post this recall letter within your facility network and forward to any customers to whom you may have distributed the product to ensure awareness. 4. Users should verify that the accession number on the BD BACTEC" Instrument loading screen matches the vial's accession number while scanning and loading onto the instrument. If an error message or other system action occurs when loading vials into the BD BACTEC" Instrument that indicates a potential issue with duplicate sequence numbers, it is recommended to follow the instructions within the message and to view the table of System Alerts located in 7 Troubleshooting of the BD BACTEC" FX Instrument User s Manual before taking any further action in vial processing. The URL link to access the BD BACTEC" FX Instrument User s Manual is noted below. There are no additional follow-up activities recommended for patient samples processed. https://eifu.bd.com/en/search/search-results?term=441385&cats=9444_9445,9441_9443,9441_9442,1185_1206,1185 5. Complete the attached Customer Response Form and return to the BD contact noted on the form whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification per FDA requirements. 6. Report any adverse health consequences experienced with the use of this product to BD. Events may also be reported to the FDA's MedWatch Adverse Event Reporting program via: Web: MedWatch website at www.fda.gov/medwatch Phone: 1-800-FDA-1088 (1-800-332-1088) Mail: MedWatch, HF-2, FDA, 5600 Fisher s Lane, Rockville, MD 20852-9787 Distributors Please Ta
Initiated
2023-09-12
Root cause
Under Investigation by firm
Distribution
Worldwide - US Nationwide distribution.
Recall number
Z-0110-2024
Recall status
Open, Classified
CDRH record ID
203431
FDA classified
2023-10-12
Recall event number
93097

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗